SCOPA 2022: All things abnormal pupil

Video

Brad Sutton, OD, FAAO, FORS, shares highlights from his SCOPA 2022 presentation, "Taking the mystery out of abnormal pupils."

Brad Sutton, OD, FAAO, FORS, clinical professor at Indiana University School of Optometry, and service chief of the Indianapolis Eye Care Center speaks with Optometry Times® editor Kassi Jackson, sharing highlights from his presentation, "Taking the mystery out of abnormal pupils," which he presented during this year's South Carolina Optometric Physicians Association's (SCOPA) annual meeting in Hilton Head.

This transcript has been lightly edited for clarity:

Brad Sutton, OD, FAAO, FORS:

This talk really focuses on all things abnormal pupil. So, abnormal pupils are kind of intimidating to practitioners because a lot of times there's pretty sinister reasons that someone has an abnormal people.

[The presentation goes] through a little bit of the pupil, pupillary pathways, the sympathetic and parasympathetic pathway that control of pupillary function, and then [I] talk about syndromes and involve pupil abnormalities, pharmacology of different drugs, and plants, and things that can get in the eye that can change the pupil.

And so we kind of cover a lot of different things that can involve a change in the pupil and in ways to help practitioners quickly determine which pupil is the abnormal pupil, and how to better classify what the underlying pathology is.

Recent Videos
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
© 2024 MJH Life Sciences

All rights reserved.